Ind-Swift Laboratories is trading 10.18% down at INR 368.10, with no clear company-specific catalyst identified for the October 30, 2026 decline. - The company recently reported strong Q2 FY27 results, including higher revenue and net profit, but those results do not explain the drop. - Broader-market headlines described defensive sentiment but did not establish a direct link to the stock’s move. - Trading volume information for the session was not provided.